PaperBehavior of protein S during long-term oral anticoagulant therapy
References (26)
- et al.
Biosynthesis and secretion of factor VII, protein C, protein S and the protein C inhibitor from a human hepatoma cell line
Blood
(1986) - et al.
Human endothelial cells synthesize protein S
Blood
(1986) Regulation of activated protein C by protein S
Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein
J. Biol. Chem.
(1986)- et al.
Plasma protein S deficiency in familial thrombotic disease
Blood
(1984) - et al.
Quantitation of human protein S in the plasma of normal and warfarin-treated individuals by radioimmuno-assay
Thromb. Res.
(1984) - et al.
An abnormal plasma distribution of protein S occurs in functional protein S deficiency
Blood
(1986) - et al.
Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
Thromb. Res.
(1987) - et al.
Participation of endothelial cells in the protein C-protein S anticoagulant pathway: The synthesis and release of protein S
J. Cell Biol.
(1986) - et al.
Biosynthesis and secretion of functional protein S by a human megakaryoblastic cell line (MEG-01)
Blood
(1987)
Protein S and the regulation of activated protein C
Semin. Thromb. Hemostas.
(1984)
High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein
Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S
Biochem. J.
(1983)
Cited by (15)
Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients
2009, Journal of Vascular SurgeryCitation Excerpt :In our study, both C4BPtot and C4BPβ levels were significantly lower in CLI patients treated with the anticoagulant warfarin in comparison to patients without such treatment. A diminution in C4BP plasma concentration was already found in patients with inherited protein S deficiency;33 and the concentration of protein S itself is known to likewise decrease during warfarin therapy.34 The molecular mechanisms for the correlation between decreased protein S and decreased C4BP levels during warfarin treatment still have to be elucidated, but our finding implies that the level of protein S influences the synthesis of C4BPtot and C4BPβ by hepatocytes.
Syndromes of thrombosis and hypercoagulability: Congenital and acquired causes of thrombosis
1998, Medical Clinics of North AmericaHypercoagulability and thrombosis
1994, Medical Clinics of North AmericaHypercoagulability and thrombosis
1992, Hematology/Oncology Clinics of North AmericaProtein S: a Central Regulator of Blood Coagulation
2022, Clinical LaboratoryThe Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies
2021, Thrombosis and Haemostasis
Copyright © 1988 Published by Elsevier Ireland Ltd.